CRISPR and Cas Genes Markets, 2028 by Product & Service (Vector-based Cas, DNA-free Cas), Application (Biomedical, Agriculture)
16 juin 2021 06h08 HE
|
Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Genes Market Size, Share & Trends Analysis Report by Product & Service (Vector-based Cas, DNA-free Cas), by Application...
Arbor Continues to Build Therapeutic Focus with Key Scientific Leaders
27 mai 2021 08h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...
Comprehensive Analysis of 250+ Key Companies Developing 250+ Novel CAR-T Therapies: DelveInsight
20 avr. 2021 20h50 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, April 20, 2021 (GLOBE NEWSWIRE) -- Comprehensive Analysis of 250+ Key Companies Developing 250+ Novel CAR-T Therapies: DelveInsight More than 50% of trials investigating...
Arbor Biotechnologies Names Devyn Smith, Ph.D., as CEO
01 avr. 2021 08h00 HE
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company unlocking nature’s genetic diversity to enable revolutionary gene editing...
Amfora Raises $6 Million with Investment from Leaps by Bayer and Spruce Capital Partners
23 mars 2021 12h56 HE
|
Amfora Inc
SAN FRANCISCO, March 23, 2021 (GLOBE NEWSWIRE) -- Amfora, Inc., a biotechnology company that is using gene editing to increase the protein density of soybean and other crops to fuel the plant-based...
Cytovia Therapeutics Opens Boston R&D Center of Excellence and Announces cGMP Manufacturing Facility, Aiming to Start Clinical Trials for its Gene-Edited iPSC CAR-NK Cells by 2022
17 mars 2021 09h39 HE
|
Cytovia Therapeutics
R&D labs for NK cell biology, gene-editing, antibody and CAR development, and NK cell pilot manufacturing opens in Natick, MACell therapy manufacturing facility with best-in-industry clinical and...
North America Digital Genome Market Report 2021: Continuous Funding by the Manufacturers and Government in the Field of Genomics - Forecast to 2028
15 mars 2021 06h03 HE
|
Research and Markets
Dublin, March 15, 2021 (GLOBE NEWSWIRE) -- The "North America Digital Genome Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. North America market for digital genome is...
Cytovia Therapeutics’ Management to Present at Three Upcoming Conferences in March
08 mars 2021 10h24 HE
|
Cytovia Therapeutics
CAMBRIDGE, Mass., March 08, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited Natural Killer (NK) and Chimeric...
Global $4.75 Billion CRISPR & Cas Genes Market Analysis 2016-2019 & Forecasts 2020-2027
01 mars 2021 07h14 HE
|
Research and Markets
Dublin, March 01, 2021 (GLOBE NEWSWIRE) -- The "CRISPR & Cas Genes Market Size, Share & Trends Analysis Report, By Product & Service; By Application; By End Use; and By Region; Segment...
Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts
08 févr. 2021 07h33 HE
|
Research and Markets
Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and...